Aims of the present study were to investigate whether FVIII, Willebrand (VWF) Antigen (Ag) and ristocetin-cofactor (VWF:RCo) predicted adverse outcomes in pregnant women with infection by SARS-Cov-2 infection. This evidence concerns the gene VWF and infection.